Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

CLVLY
CLINUVEL PHARMS LTD S/ADR
stock OTC

Inactive
Jul 17, 2026
7.35USD+3.086%(+0.22)36,763
Pre-market
0.00USD-100.000%(-7.13)0
After-hours
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Nov 7, 2021
11:03PM EST  CLINUVEL Expands Pharmaceutical Portfolio   GlobeNewswire Inc
Mar 23, 2021
08:11PM EDT  SCENESSE (afamelanotide 16mg) to be evaluated in xeroderma pigmentosum variant (XP-V)   GlobeNewswire Inc
Sep 15, 2020
03:31AM EDT  Xeroderma pigmentosum (XP) patient receives SCENESSE treatment   GlobeNewswire Inc
Aug 31, 2020
05:36AM EDT  The CLINUVEL Group today announced the opening of its state-of-the-art centralised Research & Development Centre in Singapore, operated by CLINUVEL subsidiary VALLAURIX PTE Ltd.   GlobeNewswire Inc
Jul 13, 2020
03:39AM EDT  CLINUVEL PHARMACEUTICALS today revealed PRNUMBRA, the Companys second afamelanotide product in development.   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC